Indefinite Delivery Contract 36E79722D0029
Award Date
8/31/22
Last Date to Order
8/30/23
Federal Agency
National Acquisition Center
Awardee
DR Reddy's Laboratories, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center is for the supply of chlorthalidone tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The single-award IDC has a ceiling value of $7,616,074.14 and a period of performance from November 26, 2022 to November 25, 2026, including a base year and four one-year option periods. The awardee is DR Reddy's Laboratories, Inc., a multinational...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract, valued up to $10,813,880, to Radha Pharmaceuticals Inc., a minority-owned small business manufacturer, to provide Carbidopa/Levodopa sustained-action tablets. The contract has a base period of one year from May 23, 2025 to May 22, 2026, with four one-year option periods. The contract aims to secure an uninterrupted supply of these pharmaceutical products for the VA, Department...
The federal agency National Acquisition Center, which supports the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), has awarded a single-award Indefinite Delivery Contract (IDC) to DR. Reddy's Laboratories, Inc. to provide Colchicine 0.6mg tablets. The contract has a base period of one year and four one-year option periods, with a total ceiling value of $4,752,960.45. The contract aims...
The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule contract to Helsinn Therapeutics (U.S.), Inc. to provide the drug VALCHLOR for the treatment of cutaneous T-cell lymphoma. The contract has a ceiling value of $33,573,490 and a period of performance through February 2030. This is a multiple award schedule contract that allows VA medical facilities to efficiently procure VALCHLOR on an as-needed basis. Additionally, the VA has awarded a single-award Blanket Purchase...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Baxter Healthcare Corporation on October 15, 2020, with a potential value of $30,336,036.80. The contract provides for the supply of cyclophosphamide vial injections in 1gm, 2gm, and 500mg sizes to the VA, DOD, BOP and IHS. The pre-solicitation notice indicated annual estimated requirements totaling over 12,000 vials across the three sizes, ranging from over 4,000 to 5,486...
The federal contract IDV award is for the supply of Thioridazine HCl tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) through the VA's Pharmaceutical Prime Vendor program. The single-award indefinite delivery contract was issued by the VA National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, with a ceiling value of $267,666.40 and a period of...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to DR Reddy's Laboratories, Inc., a multinational pharmaceutical company, to provide Fluorouracil 5% topical cream to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The single-award IDC has a ceiling value of $11,617,191.83 and a period of performance from November 21, 2021 to November 20, 2022, with four one-year option periods. The...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Marlex Pharmaceuticals Inc., a minority-owned and self-certified small disadvantaged business manufacturer of generic pharmaceutical and medical products. The $5.7 million contract covers the supply of alendronate tablets in different sizes to support the medical needs of the VA, Bureau of Prisons, and Indian Health Service. The contract has...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Mylan Pharmaceuticals Inc. to provide Carbidopa-Levodopa sustained-action (SA) tablets to the Department of Veterans Affairs (VA) National Acquisition Center. The contract has a 5-year period of performance from May 2020 to May 2025, with a ceiling value of $15,670,215.75. Under this IDC, Mylan will annually supply an estimated 50,537 bottles of 100mg Carbidopa-Levodopa SA tablets and 66,850 bottles of...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. The contract has a total ceiling value of $6,509,967.70 and a period of performance from September 15, 2021 through September 14, 2026. The contract is for the procurement of melatonin tablets in 1mg, 3mg, and 5mg dosages to support the medical supply needs of the VA, Department of Defense (DoD),...